CLINICAL_TRIALS
trial_result
· 2024-06-10
Clinical Trial Update: Bioequivalence Study of Perampanel Tablets 10 mg [Phase 1]
Summary
Phase 1 bioequivalence study of 10 mg perampanel tablets has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Epilepsy | Phase 1 | Status: COMPLETED